SAMC
OSIR

Shinko Asset Management Company’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Shinko Asset Management Company’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$175K Hold
35,270
– – ﹤0.01% 356
2016
Q2 		$180K Hold
35,270
– – ﹤0.01% 352
2016
Q1 		$201K Hold
35,270
– – ﹤0.01% 328
2015
Q4 		$366K Hold
35,270
– – ﹤0.01% 283
2015
Q3 		$651K Buy
+35,270
New +$681K 0.01% 205

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
QI
QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Shinko Asset Management Company's OSIR Position: Q3 2016 in Review

Shinko Asset Management Company held its Osiris Therapeutics, Inc. Common Stock (OSIR) position steady in Q3 2016 at 35,270 shares worth $175K. The position accounts for ﹤0.01% of the portfolio, ranked #356.

Shinko Asset Management Company first reported a position in OSIR in Q3 2015 and has held it in 5 quarters since. The position peaked at $651K in Q3 2015. 63 funds tracked by Wall St. Rank hold OSIR as of Q3 2016.

  • Shinko Asset Management Company held 35,270 shares of Osiris Therapeutics, Inc. Common Stock worth $175K as of Q3 2016.
  • Shinko Asset Management Company left its Osiris Therapeutics, Inc. Common Stock share count unchanged in Q3 2016.
  • Osiris Therapeutics, Inc. Common Stock made up ﹤0.01% of Shinko Asset Management Company's portfolio in Q3 2016, its #356 holding.
  • Shinko Asset Management Company first reported a position in Osiris Therapeutics, Inc. Common Stock in Q3 2015 and has held it in 5 quarters since.
  • Shinko Asset Management Company's Osiris Therapeutics, Inc. Common Stock position peaked at $651K in Q3 2015.
  • 63 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q3 2016.

Based on Shinko Asset Management Company's 13F filing for Q3 2016, filed 24 Oct 2016.